Capital Advisors Ltd’s Usana Health Sciences USNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$6K Buy
410
+229
+127% +$3.94K ﹤0.01% 1035
2026
Q2
$4K Buy
+181
New +$3.4K ﹤0.01% 1021
2025
Q4
– Sell
-241
Closed -$7K – 1585
2025
Q3
$7K Sell
241
-218
-47% -$6.71K ﹤0.01% 872
2025
Q2
$14K Buy
+459
New +$13K ﹤0.01% 715
2024
Q3
– Sell
-18
Closed -$1K – 1622
2024
Q2
$1K Buy
+18
New +$828 ﹤0.01% 1308

Other funds holding USNA

Capital Advisors Ltd's USNA Position: Q3 2026 in Review

Capital Advisors Ltd increased its Usana Health Sciences (USNA) stake by 127% in Q3 2026, buying an estimated $3.94K and bringing the position to 410 shares worth $6K. The position accounts for ﹤0.01% of the portfolio, ranked #1035.

Capital Advisors Ltd first reported a position in USNA in Q2 2024 and has held it in 5 quarters since. The position peaked at $14K in Q2 2025. 128 funds tracked by Wall St. Rank hold USNA as of Q3 2026.

  • Capital Advisors Ltd held 410 shares of Usana Health Sciences worth $6K as of Q3 2026.
  • Capital Advisors Ltd bought 229 Usana Health Sciences shares in Q3 2026, an estimated $3.94K.
  • Usana Health Sciences made up ﹤0.01% of Capital Advisors Ltd's portfolio in Q3 2026, its #1035 holding.
  • Capital Advisors Ltd first reported a position in Usana Health Sciences in Q2 2024 and has held it in 5 quarters since.
  • Capital Advisors Ltd's Usana Health Sciences position peaked at $14K in Q2 2025.
  • 128 funds tracked by Wall St. Rank held Usana Health Sciences as of Q3 2026.

Based on Capital Advisors Ltd's 13F filing for Q3 2026, filed 27 Oct 2026.